Riskpilot← Back to searchSign inGet full accessInxo A/S
A/SBankruptCVR 37758272Høstvej 4CManufacture of pharmaceutical preparations · NACE 2120Est. 20161 employeeswww.xoyourlife.com
Revenue 2024
DKK -431K
-75% vs 2023
EBITDA margin
100.1%
+78% vs 2023
Equity ratio
-166.0%
Financial strength
Net profit 2024
DKK -738K
+74% vs 2023
| Revenue | DKK -431K | -75% |
| EBITDA | DKK -431K | +78% |
| Net profit | DKK -738K | +74% |
| Total assets | DKK 2M | -7% |
| Equity | DKK -3,2M | -29% |
| Employees | 1 | — |
Legal name
Inxo A/S
CVR number
37758272
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
30. maj 2016
Share capital
DKK 462.193
Employees
1 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen eller af en direktør i forening med et bestyrelsesmedlem.
Company purpose
Virksomhedens formål er at udvikle, producere og markedsføre lægemidler og kosttilskud samt anden hermed beslægtet virksomhed.
Address
Høstvej 4C
Phone
+4522147600
Email
pm@xoyourlife.com
Website
www.xoyourlife.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -4 | -1 | -1 | 0 | -215 | -1.310 | -1.549 | -1.729 | -431 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -1.032 | -1.397 | -275 | -1 |
| EBITDA | -4 | -1 | -1 | 0 | -215 | -2.342 | -2.946 | -2.003 | -431 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -44 | -85 | -121 | -154 |
| EBIT | -4 | -1 | -1 | 0 | -215 | -2.386 | -3.030 | -2.124 | -585 |
| Net financials | 0 | -0 | -0 | -0 | -6 | -98 | -67 | -119 | -153 |
| Profit before tax | -4 | -1 | -1 | -0 | -221 | -2.484 | -3.097 | -2.243 | -738 |
| Tax | -1 | -0 | -0 | -0 | -47 | -543 | -0 | 591 | -0 |
| Net profit | -3 | -1 | -1 | -0 | -174 | -1.941 | -3.097 | -2.834 | -738 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 | 13 | 8 | 102 | 1.084 | 3.980 | 2.904 | 2.106 | 1.956 |
| Equity | -3 | -4 | -5 | 95 | 321 | 1.380 | -1.717 | -2.508 | -3.245 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 1.547 | 3.103 | 1.632 | 2.096 |
| Short-term debt | 13 | 17 | 12 | 7 | 763 | 1.052 | 1.518 | 2.982 | 3.105 |
| Total debt | 13 | 17 | 12 | 7 | 763 | 2.600 | 4.621 | 4.613 | 5.201 |
EBITDA margin
-43108600.0%
This company
15.8%
Market median
-272839341% vs market
20162024
Equity ratio
-166.0%
This company
38.2%
Market median
-535% vs market
20162024
Return on equity
-73772200.0%
This company
18.4%
Market median
-400935970% vs market
20162024
Net profit margin
-73772200.0%
This company
8.1%
Market median
-910768001% vs market
20162024
Asset turnover
-0.22×
This company
1.12×
Market median
-120% vs market
20162024
Debt / equity
1.60×
This company
0.62×
Market median
-158% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-05-30 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PC Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
JA Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Niox Holding ApS | Company | 25.0% | 25.0% | 2023 |
COPAseed A/S | Company | 15.0% | 15.0% | 2020 |
MEVA HOLDING ApS | Company | 10.0% | 10.0% | 2023 |
H.ApS | Company | 5.0% | 5.0% | 2022 |
SPINAL ApS | Company | 5.0% | 5.0% | 2022 |
Susmil Holding ApS | Company | 5.0% | 5.0% | 2022 |
NCN Advise & Invest ApS | Company | 5.0% | 5.0% | 2020 |
BRAINWASH MUSIC NETWORK ApS | Company | 0.0% | 5.0% | 2018 |
ECHOSTAR HOLDING ApS | Company | 0.0% | 5.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPINAL ApS
Inxo A/S Board members of Inxo A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pouline Charlotte Friderichsen Middleton | Chief Executive Officer | 0 companies |
| Jahangir Ashraf Khan | Chief Executive Officer | 0 companies |
| Cathrine Werthwein Andersen | Board of Directors | 0 companies |
| Emilia Caparros van Hauen | Board of Directors | 0 companies |
| Carsten Gram Andersen | Board of Directors | 0 companies |
| Mikkel Bender | Chairman | 0 companies |
| Niels Christian Nielsen | Chairman | 0 companies |
| Mikal Christian Hallstrup | Board of Directors | 0 companies |
| Brian Sussemiehl | Board of Directors | 0 companies |
| Paul James Greenall | Board of Directors | 0 companies |
| Katja Iversen | Board of Directors | 0 companies |
| Rasmus Schmiegelow | Chairman | 0 companies |